Your browser doesn't support javascript.
loading
Predicting Survival of Patients with Nonmetastatic Breast Cancer Based on Fibrinogen-to-Albumin Ratio and Lymphocyte-to-Monocyte Ratio: A Nomogram-Based Assessment.
Chen, Xiao-Yu; Long, Zhi-Qing; Huang, Han-Ying; Wen, Wen; Lin, Fei; Guo, Ling; Lin, Huan-Xin.
  • Chen XY; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, PR China.
  • Long ZQ; Department of Radiotherapy, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Huang HY; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, PR China.
  • Wen W; Department of Radiotherapy, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Lin F; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, PR China.
  • Guo L; Department of Radiotherapy, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Lin HX; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, PR China.
Breast Care (Basel) ; 18(5): 374-389, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37901049